Zosano Pharma Corp Cash and Cash Equivalents
Zosano Pharma Corp had Cash and Cash Equivalents of $13.53 million as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2022-05-13
- 2022-03-31: Cash and Cash Equivalents, at Carrying Value $13.53M.
- 2021-12-31: Cash and Cash Equivalents, at Carrying Value $11.04M.
- 2021-09-30: Cash and Cash Equivalents, at Carrying Value $17.15M.
- 2021-06-30: Cash and Cash Equivalents, at Carrying Value $22.06M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2022-03-31 | $13.53M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $11.04M 10-Q · filed 2022-05-13 |
| 2021-09-30 | $17.15M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $22.06M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $26.88M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $35.26M 10-K · filed 2022-03-17 |
| 2020-09-30 | $43.55M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $10.55M 10-Q · filed 2021-08-10 |
| 2020-03-31 | $18.56M 10-Q · filed 2021-05-12 |
| 2019-12-31 | $6.32M 10-K · filed 2021-03-11 |
| 2019-09-30 | $6.49M 10-Q · filed 2020-11-13 |
| 2019-06-30 | $14.25M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $6.14M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $9.14M 10-K · filed 2020-03-13 |
| 2018-09-30 | $11.96M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $16.20M 10-Q · filed 2019-08-14 |
| 2018-03-31 | $3.54M 10-Q · filed 2019-05-14 |
| 2017-12-31 | $11.65M 10-K · filed 2019-03-25 |
| 2017-09-30 | $13.29M 10-Q · filed 2018-11-15 |
| 2017-06-30 | $21.16M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $37.34M 10-Q · filed 2018-05-15 |
| 2016-12-31 | $15.00M 10-K · filed 2018-03-12 |
| 2016-09-30 | $19.18M 10-Q · filed 2017-11-09 |
| 2016-06-30 | $10.06M 10-Q · filed 2017-08-10 |
| 2016-03-31 | $6.56M 10-Q · filed 2017-05-09 |
| 2015-12-31 | $6.65M 10-K · filed 2018-03-12 |
| 2015-09-30 | $4.88M 10-Q · filed 2016-11-09 |
| 2015-06-30 | $8.06M 10-Q · filed 2016-08-10 |
| 2015-03-31 | $55.92M 10-Q · filed 2016-05-12 |
| 2014-12-31 | $1.21M 10-K · filed 2017-03-01 |
| 2014-09-30 | $2.30M 10-Q · filed 2015-11-10 |
| 2014-06-30 | $5.74M 10-Q · filed 2015-08-13 |
| 2014-03-31 | $5.61M 10-Q · filed 2015-05-12 |
| 2013-12-31 | $5.91M 10-K · filed 2016-03-29 |